(RTTNews) - Applied Nutrition (APN.L) said its trading in the current fiscal year to date remains strong. Excluding any contribution from the acquisition of Nutrablend, the Board now expects the Group's fiscal 2026 revenue to be ahead of current consensus market expectations at a
(RTTNews) - Applied Nutrition (APN.L) said its trading in the current fiscal year to date remains strong. Excluding any contribution from the acquisition of Nutrablend, the Board now expects the Group's fiscal 2026 revenue to be ahead of current consensus market expectations at a
Lemonade (NYSE: LMND) has been a divisive stock over its six years as a public company. While it's demonstrating powerful growth and introducing an artificial intelligence (AI)-driven alternative in a stodgy, traditional industry, does it really have a distinctive edge? And given its ongoing losses, the delightful approach to insurance may not actually be the better one. Image source: Getty Images...
Lemonade (NYSE: LMND) has been a divisive stock over its six years as a public company. While it's demonstrating powerful growth and introducing an artificial intelligence (AI)-driven alternative in a stodgy, traditional industry, does it really have a distinctive edge? And given its ongoing losses, the delightful approach to insurance may not actually be the better one. Image source: Getty Images. Continue reading
Turkey’s economy grew slower than expected in the first quarter, signaling that the the fallout from the Iran war is weighing on activity. Gross domestic product only expanded 0.1% in the first quarter from the previous three months on a seasonally-adjusted basis, slowing from 0.4% in the final quarter of last year, data published Monday showed. The reading compared with the median estimate for 0....
Turkey’s economy grew slower than expected in the first quarter, signaling that the the fallout from the Iran war is weighing on activity. Gross domestic product only expanded 0.1% in the first quarter from the previous three months on a seasonally-adjusted basis, slowing from 0.4% in the final quarter of last year, data published Monday showed. The reading compared with the median estimate for 0.3% growth in a Bloomberg survey of economists. On an annual basis, the economy 2.5% compared with 3.4% in the previous quarter. The data come as Turkey faces renewed risks from the conflict in Iran, a shock that has pushed up energy-market volatility and complicated the Turkish central bank’s efforts to curb inflation. Turkey imports most of its oil and natural gas, making the economy particularly vulnerable to higher global energy prices. The central bank reversed its easing cycle earlier this year and raised a key interest rate to contain market volatility stemming from a broader selloff in emerging markets assets. The next rate-setting meeting is scheduled for June 11.
Akeso CFO Bing Wang says the Chinese biotech firm is investing “significantly” to expand manufacturing of its lung cancer drug as it anticipates growing demand in China and the US. He speaks exclusively to Bloomberg after Akeso presented positive results for the drug at the American Society of Clinical Oncology’s annual meeting. (Source: Bloomberg)
Akeso CFO Bing Wang says the Chinese biotech firm is investing “significantly” to expand manufacturing of its lung cancer drug as it anticipates growing demand in China and the US. He speaks exclusively to Bloomberg after Akeso presented positive results for the drug at the American Society of Clinical Oncology’s annual meeting. (Source: Bloomberg)